IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Brad C. Dunlap who wrote (165)	12/5/1996 6:41:00 PM
From: I. Luttichuys	of 1762

Hello Brad, IDEC was quite strong today. Eric Hecht's position is interesting. I feel, as you do, that the low side-effect profile, high efficacy, and low cost of C2B8 make it a natural front-line choice. I believe it will be the oncologists and healthcare management who will make this determination in the end. I wish you every success in your efforts representing these NHL patients. If I do not hear from you again before the conference ... have a safe and productive trip. BENNETT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next